Crossmark

Therapeutic hypernatremia management during continuous renal replacement therapy with elevated intracranial pressures and respiratory failure

Crossref DOI link: https://doi.org/10.1007/s11154-019-09483-2

Published Online: 2019-03-08

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fülöp, Tibor

Zsom, Lajos

Rodríguez, Rafael D.

Chabrier-Rosello, Jorge O.

Hamrahian, Mehrdad

Koch, Christian A.
License Information

Text and Data Mining valid from 2019-03-01
More Information

Article History

First Online: 8 March 2019

Change Date: 6 May 2019

Change Type: Correction

Change Details: The authors would like to report an error in the formula describing the correction factor for the protein content in the serum/plasma.

Compliance with ethical standards

:

: Dr. Zsom is a current employee of Fresenius Medical Care (FMC) Hungary and Dr. Fülöp is a former employee of FMC Hungary. Dr. Fülöp is a current employee of the United States Veterans Health Administration. However, the views and opinions expressed herewith do not reflect the official views or opinion or endorsed by the FMC Hungary or the United States Veteran Health Administrations. None of the other authors declares a conflict of interest with this article.